Potential Antimicrobial Properties of Coffee Beans and Coffee By-Products Against Drug-Resistant Vibrio cholerae

被引:14
|
作者
Rawangkan, Anchalee [1 ,2 ]
Siriphap, Achiraya [1 ]
Yosboonruang, Atchariya [1 ]
Kiddee, Anong [1 ]
Pook-In, Grissana [1 ]
Saokaew, Surasak [3 ,4 ,5 ]
Sutheinkul, Orasa [6 ]
Duangjai, Acharaporn [1 ,2 ]
机构
[1] Univ Phayao, Sch Med Sci, Phayao, Thailand
[2] Univ Phayao, Sch Med Sci, Div Physiol, Unit Excellence Res & Prod Dev Coffee, Phayao, Thailand
[3] Univ Phayao, Sch Pharmaceut Sci, Div Social & Adm Pharm, Dept Pharmaceut Care, Phayao, Thailand
[4] Univ Phayao, Sch Pharmaceut Sci, Ctr Hlth Outcomes Res & Therapeut Safety Cohorts, Phayao, Thailand
[5] Univ Phayao, Sch Pharmaceut Sci, Unit Excellence Clin Outcomes Res & Integrat UNIC, Phayao, Thailand
[6] Mahidol Univ, Fac Publ Hlth, Bangkok, Thailand
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
关键词
antimicrobial activity; coffee by-products; coffee extract; drug-resistant; Vibrio cholerae; ANTIBACTERIAL ACTIVITY; CHLOROGENIC ACID; CAFFEIC ACID; IN-VITRO; HPLC-DAD; PULP; TOXIN; FERMENTATION; ANTIOXIDANT; INHIBITION;
D O I
10.3389/fnut.2022.865684
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Vibrio cholerae is the causative organism of the cholera epidemic, and it remains a serious global health problem, particularly the multidrug-resistant strain, despite the development of several generic drugs and vaccines over time. Natural products have long been exploited for the treatment of various diseases, and this study aimed to evaluate the in vitro antibacterial activity of coffee beans and coffee by-products against V. cholerae antimicrobial resistant strains. A total of 9 aqueous extracts were investigated, including light coffee (LC), medium coffee (MC), dark coffee (DC), dried green coffee (DGC), dried red coffee (DRC), fresh red coffee (FRC), Arabica leaf (AL), Robusta leaf (RL), and coffee pulp (CP). The influential coffee phytochemicals, i.e., chlorogenic acid (CGA), caffeic acid (CA), and caffeine, were determined using HPLC. The antibacterial properties were tested by agar well-diffusion techniques, and the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were further determined against 20 V. cholerae isolates. The results revealed that all tested strains were sensitive to coffee extracts, with MIC and MBC values in the range of 3.125-25.0 mg/mL and 12.5-50.0 mg/mL, respectively. With a MIC of 6.25 mg/mL, DGC, DRC, and CP appeared to be the most effective compounds against 65, 60, and 55% of clinical strains, respectively. The checkerboard assay revealed that the combination of coffee extract and tetracycline was greater than either treatment alone, with the fractional inhibitory concentration index (FICI) ranging from 0.005 to 0.258. It is important to note that CP had the lowest FICI (0.005) when combined with tetracycline at 60 ng/mL, which is the most effective dose against V. cholerae six-drug resistance strains (azithromycin, colistin, nalidixic acid, sulfamethoxazole, tetracycline, and trimethoprim), with a MIC of 47.5 mu g/mL (MIC alone = 12.5 mg/mL). Time killing kinetics analysis suggested that CA might be the most effective treatment for drug-resistant V. cholerae as it reduced bacterial growth by 3 log(10) CFU/mL at a concentration of 8 mg/mL within 1 h, via disrupting membrane permeability, as confirmed by scanning electron microscopy (SEM). This is the first report showing that coffee beans and coffee by-product extracts are an alternative for multidrug-resistant V. cholerae treatment.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates
    Benincasa, M
    Scocchi, M
    Podda, E
    Skerlavaj, B
    Dolzani, L
    Gennaro, R
    PEPTIDES, 2004, 25 (12) : 2055 - 2061
  • [42] EFFICACY OF AN ANTIMICROBIAL PEPTIDE MIMIC AGAINST DRUG-RESISTANT PSEUDOMONAS AERUGINOSA IN A BIOFILM FORM
    Savage, P. B.
    Lew, C. R.
    Carl, G.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 313 - 313
  • [43] Study of the antimicrobial activity of carvacrol and its mechanism of action against drug-resistant bacteria
    Zhi, Ziling
    Zhou, Peng
    He, Tenghui
    Chen, Sisi
    Qian, Xiping
    Ye, Yanyan
    Wong, Wing-Leung
    Li, Song
    Sun, Ning
    Yuan, Wenchang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 757
  • [44] Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis
    Islam, Md Imtiazul
    Seo, Hoonhee
    Kim, Sukyung
    Sadu, Venkata S.
    Lee, Kee-In
    Song, Ho-Yeon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Antimicrobial Efficacy of Decamethoxin (DMT) Against Drug-Resistant Mycobacterium Abscessus Clinical Isolates
    Faasuamalie, P.
    Gupta, S.
    Olivier, K. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [46] Synthesis and anthelmintic properties of arylquinolines with activity against drug-resistant nematodes
    Rossiter, S
    Péron, JM
    Whitfield, PJ
    Jones, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4806 - 4808
  • [47] Nutritional potential and inhibitory activity of bread fortified with green coffee beans against enzymes involved in metabolic syndrome pathogenesis
    Jakubczyk, Anna
    Swieca, Michal
    Gawlik-Dziki, Urszula
    Dziki, Dariusz
    LWT-FOOD SCIENCE AND TECHNOLOGY, 2018, 95 : 78 - 84
  • [48] Genetic characteristics of drug-resistant Vibrio cholerae O1 causing endemic cholera in Dhaka, 2006-2011
    Rashed, Shah M.
    Mannan, Shahnewaj B.
    Johura, Fatema-tuz
    Islam, M. Tarequl
    Sadique, Abdus
    Watanabe, Haruo
    Sack, R. Bradley
    Huq, Anwar
    Colwell, Rita R.
    Cravioto, Alejandro
    Alam, Munirul
    JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 61 (12) : 1736 - 1745
  • [49] Hybrid Molecules with Potential Activity against Drug-resistant Cancer (Part II)
    Feng, Lian-Shun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (17) : 1392 - 1392
  • [50] In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis
    Marques, Joaquim Trigo
    De Faria, Catarina Frazao
    Reis, Marina
    Machado, Diana
    Santos, Susana
    Santos, Maria da Soledade
    Viveiros, Miguel
    Martins, Filomena
    De Almeida, Rodrigo F. M.
    FRONTIERS IN PHARMACOLOGY, 2022, 13